Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Director/PDMR dealing

31 Dec 2025 07:00

RNS Number : 2762N
Gattaca PLC
31 December 2025
Β 

31 December 2025

Gattaca plc

Β 

("Gattaca" or the "Company")

Β 

Director/PDMR dealing

Β 

Gattaca, the specialist staffing solutions business, announces that Matthew Wragg and Oliver Whittaker have sold, in aggregate, 58,572 Ordinary Shares to assist satisfying tax liabilities resulting from the exercise options on 16 December 2025.

Β 

Executive Directors

Title

Ordinary Shares sold

Matt Wragg

Chief Executive Officer

41,661

Oliver Whittaker

Chief Financial Officer

16,911

Β 

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further details of the transactions on 30 December 2025.

Β 

For further information please contact:

Gattaca plc

+44 (0) 1489 898989

Matthew Wragg, Chief Executive Officer

Oliver Whittaker, Chief Financial OfficerΒ 

Β 

Panmure Liberum Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Edward Mansfield

Will King

Β 

IFC Advisory

+44 (0) 20 3934 6632

Tim Metcalfe

Graham Herring

Florence Chandler

Β 

Β 

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Matthew Wragg

2

Reason for the notification

a)

Β 

Position/status

CEO

b)

Β 

Initial notification/Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Gattaca plc

b)

LEI

213800LM81ZQ9V9G6866

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00B1FMDQ43

b)

Β 

Nature of the transaction

Β 

Β 

Β 

Sale of Ordinary Shares

Β 

c)

Β 

Price(s) and volume(s)

Sale of Ordinary Shares

Β 

Price(s)

Volume(s)

89.5049 pence

41,661

d)

Β 

Aggregated information

- Aggregated volume

- Price

Sale of Ordinary Shares

Β 

Price

Volume

Β£37,228.64

41,661

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

Β 

30 December 2025

Β 

Β 

f)

Place of the transaction

London Stock Exchange

Β 

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Oliver Whittaker

2

Reason for the notification

a)

Β 

Position/status

CFO

b)

Β 

Initial notification/Amendment

Initial notification

Β 

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Gattaca plc

b)

LEI

213800LM81ZQ9V9G6866

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 1 penny each

Identification code

GB00B1FMDQ43

b)

Β 

Nature of the transaction

Β 

Β 

Β 

Sale of Ordinary Shares

Β 

c)

Β 

Price(s) and volume(s)

Sale of Ordinary Shares

Β 

Price(s)

Volume(s)

89.5049 pence

16,911

d)

Β 

Aggregated information

- Aggregated volume

- Price

Sale of Ordinary Shares

Β 

Price

Volume

Β£15,136.17

16,911

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

Β 

30 December 2025

Β 

Β 

f)

Place of the transaction

London Stock Exchange

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPKDBPPBDKDBN
Date   Source Headline
15th Feb 20237:00 amRNSTrading Statement
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
14th Dec 20223:02 pmRNSIssue of Ordinary Shares & Total Voting Rights
6th Dec 20221:55 pmRNSDirector/PDMR Shareholding
6th Dec 202212:55 pmRNSResult of AGM
3rd Nov 20227:00 amRNSPreliminary Results for the year ended 31 July 22
3rd Oct 202211:03 amRNSBlock Listing Six Monthly Return
29th Sep 20224:54 pmRNSEBT Share Purchase Programme
17th Aug 20227:00 amRNSTrading Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20229:06 amRNSSecond Price Monitoring Extn
8th Jul 20229:00 amRNSPrice Monitoring Extension
6th May 202211:55 amRNSDirector/PDMR Shareholding
4th Apr 20224:20 pmRNSConfirmation of Director Appointment
1st Apr 20229:35 amRNSBlock listing six monthly return
31st Mar 20227:00 amRNSInterim Results
15th Mar 20227:00 amRNSBoard Succession
18th Jan 20229:05 amRNSSecond Price Monitoring Extn
18th Jan 20229:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTrading Update
16th Dec 20211:40 pmRNSDirector/PDMR Shareholding
8th Dec 20214:14 pmRNSResult of AGM
8th Dec 20214:10 pmRNSDirectorate Change
2nd Dec 202111:06 amRNSSecond Price Monitoring Extn
2nd Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20219:05 amRNSSecond Price Monitoring Extn
4th Nov 20219:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSPreliminary Results for the year ended 31 July 21
1st Oct 20219:09 amRNSBlock Listing Six Monthly Return
20th Sep 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSTrading Update
13th Jul 202110:50 amRNSDirector/PDMR Shareholding
17th Jun 202112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20214:20 pmRNSDirector/PDMR Shareholding
8th Jun 202111:00 amRNSPrice Monitoring Extension
26th May 20214:40 pmRNSSecond Price Monitoring Extn
26th May 20214:35 pmRNSPrice Monitoring Extension
21st May 20215:28 pmRNSDirector/PDMR Shareholding
21st May 202111:58 amRNSHolding(s) in Company
21st May 20217:00 amRNSTrading Update - Improved Outlook
14th May 202111:37 amRNSHolding(s) in Company
13th May 20211:24 pmRNSHolding(s) in Company
11th May 202111:34 amRNSHolding(s) in Company
23rd Apr 20212:53 pmRNSHolding(s) in Company
1st Apr 20219:29 amRNSBlock Listing Six Monthly Return
31st Mar 20217:00 amRNSInterim Results for the six months ended 31 Jan 21
17th Feb 20217:00 amRNSTrading Update
8th Dec 20201:05 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.